InvestorsHub Logo
icon url

PRmaniac

03/22/19 10:39 AM

#25863 RE: PhylosopherKyng #25860

That's why real research reports get true peer reviews. Maybe the peer reviewer is just a 5th grader....LOL

Yes, seems a little sketchy, and that makes it less likely to be referenced by others or accepted by the scientific community.
icon url

PhenixBleu

03/23/19 9:59 AM

#25934 RE: PhylosopherKyng #25860

Dude, you spelled his name wrong. It's Jeffrey Osborn. The more important fact is he does cardiovascular research. The bio link shows he is the person behind the research using Kali's Blue Dream cannabis formulation.

Our CEO would be sued if he issued an unauthorized report on Osborn's research.

https://bio.as.uky.edu/users/jlosbo3

his name is spelled "Jeffery Osborn" and his bio does not state anything about him being a part of this research

icon url

AISI304

03/23/19 11:24 AM

#25936 RE: PhylosopherKyng #25860

Jeffery Osborn seems sketchy. Name not on report. Probably didn't want report to be attributed to him.
I think PRmaniac pretty much summed it up. Gonna watch KALY long time before considering buying.
Maybe later this year with actual results may be cool, but, for now, probably watch KALY as a flip play.
That's all KALY has been doing since January, up...down...up...down, just have to play its P&D moves.



PRmaniac Friday, 03/22/19 10:25:26 AM
Re: PhylosopherKyng post# 25833
Post # 25850 of 25936
So the CBD report was fake. Looks like the PR was written by a 5th-grader.

and the so-called report fails to list the authors, location, conditions of study.